ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 73 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13,628 | -18.6% | 4,117 | -19.7% | 0.00% | – |
| Q1 2024 | $16,745 | -48.9% | 5,127 | -45.1% | 0.00% | – |
| Q4 2023 | $32,784 | -87.0% | 9,340 | -75.2% | 0.00% | – |
| Q3 2023 | $251,266 | -20.9% | 37,594 | -0.8% | 0.00% | – |
| Q2 2023 | $317,679 | +1223.7% | 37,897 | +616.5% | 0.00% | – |
| Q1 2022 | $24,000 | +20.0% | 5,289 | +6.2% | 0.00% | – |
| Q4 2021 | $20,000 | -55.6% | 4,982 | -2.9% | 0.00% | – |
| Q3 2021 | $45,000 | -22.4% | 5,132 | 0.0% | 0.00% | – |
| Q2 2021 | $58,000 | +480.0% | 5,132 | +31.5% | 0.00% | – |
| Q1 2020 | $10,000 | -56.5% | 3,904 | 0.0% | 0.00% | – |
| Q4 2019 | $23,000 | +35.3% | 3,904 | +19.0% | 0.00% | – |
| Q3 2019 | $17,000 | -15.0% | 3,282 | 0.0% | 0.00% | – |
| Q2 2019 | $20,000 | -33.3% | 3,282 | 0.0% | 0.00% | – |
| Q1 2019 | $30,000 | +11.1% | 3,282 | 0.0% | 0.00% | – |
| Q4 2018 | $27,000 | -18.2% | 3,282 | +39.1% | 0.00% | – |
| Q3 2018 | $33,000 | +73.7% | 2,360 | 0.0% | 0.00% | – |
| Q2 2018 | $19,000 | – | 2,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 1,877,305 | $10,025,000 | 5.86% |
| Prosight Management, LP | 1,210,800 | $6,466,000 | 3.46% |
| Perceptive Advisors | 11,350,085 | $60,609,000 | 1.76% |
| JOHNSON & JOHNSON | 394,834 | $2,108,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $3,738,000 | 0.46% |
| APOGEM CAPITAL LLC | 85,091 | $454,000 | 0.45% |
| 683 Capital Management, LLC | 700,000 | $3,738,000 | 0.29% |
| EAM Investors, LLC | 233,638 | $1,248,000 | 0.27% |
| Verition Fund Management LLC | 4,804,478 | $12,840,828 | 0.14% |
| WOODSTOCK CORP | 129,179 | $690,000 | 0.10% |